RDY Jun 2024 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 09:53AM EDT
| Previous Close | 2.3000 |
| Open | 0.7000 |
| Bid | 1.0000 |
| Ask | 4.2000 |
| Strike | 70.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 0.7000 - 0.7000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 62 |
Business WireDr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
HYDERABAD, India, May 28, 2024--Dr. Reddy's Laboratories Ltd. today announced the appointment of Milan Kalawadia as Chief Executive Officer, North America.
Business WireAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
HYDERABAD, India & REYKJAVIK, Iceland, May 21, 2024--Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva®.
ZacksWhy Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.